The Lynx Group

Conference Correspondent

News, views, and coverage of important topics and discussions from oncology conferences and events.

Conference Correspondent — October 30, 2020
After Medicare, employers are the largest purchasing group in cancer care. In this session, experts offer employers’ perspectives on health benefit plans, as well as issues that frequently arise when designing plans, managing costs, and defining value.
Read Article

Conference Correspondent — October 29, 2020
Cancer Centers of Excellence play an important role in the delivery of cancer care. Future expansion into the communities and remotely will benefit patients, employers, and payers, and may help to close health disparity gaps.
Read Article

Conference Correspondent — October 29, 2020
The COVID-19 pandemic has significantly affected all areas of the healthcare system. In this session, experts offer pharmaceutical perspectives on the innovations that may result from the current public health crisis and the future of cancer care.
Read Article

Conference Correspondent — October 23, 2020
Greg Simon, who led the Cancer Moonshot program under the Obama-Biden administration, asserts that the COVID-19 pandemic has exposed vast chasms of inequity in cancer care, and challenges listeners to think in new ways about how we deliver and pay for care.
Read Article

Conference Correspondent — October 23, 2020
From new approaches for sequencing therapy to preparing for an incoming tsunami of delayed diagnoses after months of missed cancer screenings, community cancer providers have a lot to manage in the era of COVID-19.
Read Article

Conference Correspondent — October 23, 2020
From the CMS’s Oncology Care Model to future prospects for Oncology Care First and other value-based and alternative payment models, payers share their insights on what is most likely to succeed to improve care and manage costs in oncology.
Read Article

Conference Correspondent — October 23, 2020
From quality-adjusted life-years to social determinants of health to the international pricing index, top experts in cancer care economics discussed strategies for achieving the Holy Grail of true value-based pricing for pharmaceuticals.
Read Article

Conference Correspondent — October 16, 2020
Uncertainty reigns in Washington with the upcoming election only weeks away. What can cancer care stakeholders expect from legislators and policymakers over the next several weeks, during the lame duck session, and in 2021?
Read Article

Conference Correspondent — October 16, 2020
The top priority for employers regarding their employees’ cancer care coverage is ensuring access to state-of-the-art care. Learn how employers are trying to close the gap between “typical” and “optimal” care.
Read Article

Conference Correspondent — October 16, 2020
Telling the story of the Oncology Care Model and its performance over the past 5 years through some of the best-performing practices.
Read Article

Page 1 of 38

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: